Preferred Practice Patterns for Presumed Viral Kerato-Conjunctivitis in Central India

Authors

  • Prakashchand Agarwal People’s College of Medical Sciences and Research, Bhopal
  • Saroj Gupta People’s College of Medical Sciences and Research, Bhopal
  • Anjali Sharma People’s College of Medical Sciences and Research, Bhopal
  • V K Saini People’s College of Medical Sciences and Research, Bhopal

Keywords:

Preferred pattern, steroids, viral conjunctivitis

Abstract

Introduction: Epidemic viral kerato-conjunctivitis is a common tropical infection. No standard guidelines exist for treating this self limiting illness. Various treatment patterns are prevalent which may be non-scientific.

Material and Methods: Ophthalmologists were requested to fill questionnaire based survey to answer related questions to understand the preferred practice patterns in central India. Out of 400 forms, 378 completed forms were analyzed.

Results: In a presumed viral disease, moxifloxacin (0.5%) was the most common antibiotic among 62.7% followed by gatifloxacin (0.3%), ofloxacin and ciprofloxacin. Three hundred and forty two (90%) responders preferred using topical steroids, while 87 % preferred fixed dose combination of antibiotics and steroids. Seventy seven percent doctors prefer to use topical decongestant and lubricating eye drops as supportive therapy. Eighty two percent doctors preferred to use non steroidal anti-inflammatory agents for their patients.

Conclusion: Irrational use of higher generation antibiotics is prevalent among ophthalmologists for self limiting presumed viral conjunctivitis. No standard guidelines exist for the same. Topical steroids should be used with extreme caution for ocular diseases.

References

Reed K. Epidemic viral KC diagnosis and management . J Am Optom Ass 1983; 4: 141-4

Marangon FB, Miller D, Alfonso E. Laboratory results in ocular viral diseases: implications in clinical-laboratory correlation. Arq Bras Oftalmol. 2007 Mar-Apr;70(2):189-94.

Tarabishy AB, Jeng BH. Bacterial conjunctivitis: a review for internists. Cleve Clin J Med. 2008 Jul;75(7):507-12.

Isenberg SJ et al studied the role of povidine –iodine (1.25%) ophthalmic solution and antibiotic ointment (neomycin-polymyxin B-gramicidin) and reported that both were equally efficacious in treating bacterial and chlymadial conjunctivitis and not effective in viral conjunctivitis.

Isenberg SJ, Apt L, Valenton M, Del Signore M, Cubillan L, Labrador MA, Chan P, Berman NG. A controlled trial of povidone-iodine to treat infectious conjunctivitis in children. Am J Ophthalmol. 2002 Nov;134(5):681-8.

Sheikh A, Hurwitz B. Topical antibiotics for acute bacterial conjunctivitis: Cochrane systematic review and meta-analysis update. Br J Gen Pract. 2005 Dec;55(521):962-4.

Fintelmann RE, Hoskins EN, Lietman TM, Keenan JD, Gaynor BD, Cevallos V, Acharya NR. Topical fluoroquinolone use as a risk factor for in vitro fluoroquinolone resistance in ocular cultures. Arch Ophthalmol. 2011 Apr;129(4):399-402.

Park SH, Lim JA, Choi JS, Kim KA, Joo CK. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea. 2009 Jan;28(1):68-72.

McDonald M, Blondeau JM. Emerging antibiotic resistance in ocular infections and the role of fluoroquinolones. J Cataract Refract Surg. 2010 Sep;36(9):1588-98.

Everitt HA, Little PS, Smith PW. A randomized controlled trial of management strategies for acute infective conjunctivitis in general practice. BMJ. 2006 Aug 12;333(7563):321.

Wilkins MR, Khan S, Bunce C, Khawaja A, Siriwardena D, Larkin DF.A randomised placebo-controlled trial of topical steroid in presumed viral conjunctivitis. Br J Ophthalmol. 2011 Sep;95(9):1299-303.

Romanowski EG, Roba LA, Wiley L, Araullo-Cruz T, Gordon YJ. The effects of corticosteroids of adenoviral replication. Arch Ophthalmol. 1996 May;114(5):581-5.

Pelletier JS, Stewart K, Trattler W, Ritterband DC, Braverman S, Samson CM, Liang B, Capriotti JA. A combination povidone-iodine 0.4%/dexamethasone 0.1% ophthalmic suspension in the treatment of adenoviral conjunctivitis. Adv Ther. 2009 Aug;26(8):776-83.

Gordon YJ, Araullo-Cruz T, Romanowski EG. The effects of topical nonsteroidal anti-inflammatory drugs on adenoviral replication. Arch Ophthalmol. 1998 Jul;116(7):900-5.

Shiuey Y, Ambati BK, Adamis AP. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis. Ophthalmology. 2000 Aug;107(8):1512-7.

Downloads

Published

2014-03-31

How to Cite

1.
Agarwal P, Gupta S, Sharma A, Saini VK. Preferred Practice Patterns for Presumed Viral Kerato-Conjunctivitis in Central India. Natl J Community Med [Internet]. 2014 Mar. 31 [cited 2024 May 7];5(01):54-6. Available from: https://www.njcmindia.com/index.php/file/article/view/1315

Issue

Section

Original Research Articles